
Nxera Pharma Co., Ltd.
4565 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区赤坂9−7−2
- Website:
- https://www.nxera.life/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Nxera Pharma Co., Ltd. is a pioneering Japanese biopharmaceutical company dedicated to revolutionizing medicine through advanced science and technology. With a mission to accelerate the development of life-changing therapies, Nxera focuses on creating innovative solutions that enhance patient care. The company is committed to pushing the boundaries of drug design, specifically through its expertise in structure-based methodologies. By forging strategic partnerships and pursuing groundbreaking discoveries, Nxera aims to bring forth the next generation of medical treatments. With a robust pipeline and a dedication to addressing unmet medical needs, Nxera Pharma is at the forefront of delivering better health outcomes for patients worldwide.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-04-16 08:57 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 41.6 KB | |
2025-04-16 08:55 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 41.6 KB | |
2025-04-16 08:53 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 39.8 KB | |
2025-04-16 08:51 |
Inside Information Statement
臨時報告書
|
Japanese | 32.4 KB | |
2025-03-26 08:42 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 42.2 KB | |
2025-03-26 08:41 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 42.2 KB | |
2025-03-26 08:40 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 40.4 KB | |
2025-03-26 08:38 |
Inside Information Statement
臨時報告書
|
Japanese | 28.0 KB | |
2025-03-26 08:37 |
Internal Control over Financial Reporting
内部統制報告書-第35期(2024/01/01-2024/12/31)
|
Japanese | 23.8 KB | |
2025-03-26 08:36 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
2025-03-26 08:35 |
Annual Report
有価証券報告書-第35期(2024/01/01-2024/12/31)
|
Japanese | 1.3 MB | |
2025-02-14 07:47 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 38.2 KB | |
2025-02-14 07:46 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 38.2 KB | |
2025-02-14 07:45 |
Regulatory News Service
訂正有価証券届出書(参照方式)
|
Japanese | 36.4 KB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
![]() |
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
![]() |
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
Alma Yesodot Ltd. | Israel | KVSR | ||
![]() |
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
Ananda Pharma Plc | United Kingdom | N/A | ||
![]() |
AnGes, Inc. | Japan | 4563 |